T-cell allorecognition: a case of mistaken identity or déjà vu?

Trends in Immunology

Volumn 29, Issue 5, 2008, Pages 220-226

  Archbold, Julia K ^a   Macdonald, Whitney A ^a   Burrows, Scott R ^b   Rossjohn, Jamie ^a   McCluskey, James ^c  

^a MONASH UNIVERSITY   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; T LYMPHOCYTE RECEPTOR;

ALLOIMMUNITY; CELL ACTIVITY; CELL INTERACTION; CELL STRUCTURE; CROSS REACTION; DEJA VU; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR MIMICRY; NONHUMAN; REVIEW; STRUCTURE ANALYSIS; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; CROSS REACTIONS; CRYSTALLOGRAPHY, X-RAY; HUMANS; ISOANTIGENS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR MIMICRY; MULTIPROTEIN COMPLEXES; PEPTIDES; PROTEIN CONFORMATION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; STRUCTURAL HOMOLOGY, PROTEIN; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 42749083624     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2008.02.005     Document Type: Review

References (72)

1. Krogsgaard M., and Davis M.M. How T cells 'see' antigen. Nat. Immunol. 6 (2005) 239-245
2. Margulies D., et al. Major histocompatibility complex (MHC) molecules: structure, function, and genetics. In: Paul W. (Ed). Fundamental Immunology. 6th edn (2008), Lippincott Williams & Wilkins
3. Burrows S.R., et al. Have we cut ourselves too short in mapping CTL epitopes?. Trends Immunol. 27 (2006) 11-16
4. Robinson J., et al. IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res. 31 (2003) 311-314
5. Kjer-Nielsen L., et al. The structure of HLA-B8 complexed to an immunodominant viral determinant: peptide-induced conformational changes and a mode of MHC class I dimerization. J. Immunol. 169 (2002) 5153-5160
6. Tynan F.E., et al. High resolution structures of highly bulged viral epitopes bound to Major Histocompatibility Complex class I: implications for T cell receptor engagement and T cell immunodominance. J. Biol. Chem. 280 (2005) 23900-23909
7. Rudolph M.G., et al. How TCRs bind MHCs, peptides, and coreceptors. Annu. Rev. Immunol. 24 (2006) 419-466
8. Garcia K.C., et al. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science 279 (1998) 1166-1172
9. Krogsgaard M., et al. Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation. Mol. Cell 12 (2003) 1367-1378
10. Tynan F.E., et al. T cell receptor recognition of a 'super-bulged' major histocompatability complex class I-bound peptide. Nat. Immunol. 6 (2005) 1114-1122
11. Tynan F.E., et al. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule. Nat. Immunol. 8 (2007) 268-276
12. Zinkernagel R.M., and Doherty P.C. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248 (1974) 701-702
13. Sherman L.A., and Chattopadhyay S. The molecular basis of allorecognition. Annu. Rev. Immunol. 11 (1993) 385-402
14. Afzali B., et al. Allorecognition and the alloresponse: clinical implications. Tissue Antigens 69 (2007) 545-556
15. Suchin E.J., et al. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J. Immunol. 166 (2001) 973-981
16. Colf L.A., et al. How a single T cell receptor recognizes both self and foreign MHC. Cell 129 (2007) 135-146
17. Reiser J.-B., et al. A T cell receptor CDR3β loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex. Immunity 16 (2002) 345-354
18. Doxiadis II, et al. Association between specific HLA combinations and probability of kidney allograft loss: the taboo concept. Lancet 348 (1996) 850-853
19. Maruya E., et al. HLA matching: identification of permissible HLA mismatches. Clin. Transpl. (1993) 511-520
20. CD8 cell alloreactivity. Am. J. Transplant. 8 (2008) 121-132
21. Burrows S.R., et al. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity. Eur. J. Immunol. 27 (1997) 1726-1736
22. Felix N.J., and Allen P.M. Specificity of T cell alloreactivity. Nat. Rev. Immunol. 7 (2007) 942-953
23. Matzinger P., and Bevan M.J. Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens? Cell. Immunol. 29 (1977) 1-5
24. Bevan M.J. High determinant density may explain the phenomenon of alloreactivity. Immunol. Today 5 (1984) 128-130
25. Mason D. A very high level of crossreactivity is an essential feature of the T cell receptor. Immunol. Today 19 (1998) 395-404
26. Santori F.R., et al. TCRβ chain that forms peptide-independent alloreactive TCR transfers reduced reactivity with irrelevant peptide/MHC complex. J. Immunol. 178 (2007) 6109-6114
27. Felix N.J., et al. Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes. Nat. Immunol. 8 (2007) 388-397
28. Blok R., et al. CD8 expression alters the fine specificity of an alloreactive MHC class I-specific T hybridoma. Int. Immunol. 4 (1992) 455-466
29. Huseby E.S., et al. How the T cell repertoire becomes peptide and MHC specific. Cell 122 (2005) 247-260
30. Huseby E.S., et al. Interface-disrupting amino acids establish specificity between T cell receptors and complexes of major histocompatibility complex and peptide. Nat. Immunol. 7 (2006) 1191-1199
31. Jerne N.K. The somatic generation of immune recognition. Eur. J. Immunol. 1 (1971) 1-9
32. Feng D., et al. Structural evidence for a germline-encoded T cell receptor-major histocompatibility complex interaction 'codon'. Nat. Immunol. 8 (2007) 975-983
33. Crawford F., et al. Use of baculovirus MHC/peptide display libraries to characterize T cell receptor ligands. Immunol. Rev. 210 (2006) 156-170
34. Luz J.G., et al. Structural comparison of allogeneic and syngeneic T cell receptor-peptide-major histocompatibility complex complexes: a buried alloreactive mutation subtly alters peptide presentation substantially increasing V(beta) Interactions. J. Exp. Med. 195 (2002) 1175-1186
35. Archbold J.K., et al. Alloreactivity between disparate cognate and allogeneic pMHC-I complexes is the result of highly focused, peptide-dependent structural mimicry. J. Biol. Chem. 281 (2006) 34324-34332
36. Lopez D., et al. Peptide-presenting similarities among functionally distant HLA-B27 subtypes revealed by alloreactive T lymphocytes of unusual specificity. J. Immunol. 148 (1992) 996-1002
37. Macdonald W.A., et al. A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. J. Exp. Med. 198 (2003) 679-691
38. Hennecke J., et al. Structure of a covalently stabilized complex of a human alphabeta T cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1. EMBO J. 19 (2000) 5611-5624
39. Hennecke J., and Wiley D.C. Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity. J. Exp. Med. 195 (2002) 571-581
40. Reiser J.B., et al. Crystal structure of a T cell receptor bound to an allogeneic MHC molecule. Nat. Immunol. 1 (2000) 291-297
41. Garboczi D.N., and Biddison W.E. Shapes of MHC restriction. Immunity 10 (1999) 1-7
42. Auchincloss H., and Sachs D.H. Transplantation and graft rejection. In: Paul W.E. (Ed). Fundamental Immunology. 3rd edn (1993), Raven Press 1099-1141
43. Smith K.J., et al. Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. Immunity 4 (1996) 215-228
44. Barouch D., et al. HLA-A2 subtypes are functionally distinct in peptide binding and presentation. J. Exp. Med. 182 (1995) 1847-1856
45. Nakayama S., et al. Effect of single amino acid substitution at residue 167 of HLA-B51 on binding of antibodies and recognition of T cells. Hum. Immunol. 39 (1994) 211-219
46. Paradela A., et al. The same natural ligand is involved in allorecognition of multiple HLA-B27 subtypes by a single T cell clone: role of peptide and the MHC molecule in alloreactivity. J. Immunol. 161 (1998) 5481-5490
47. Fleischhauer K., et al. Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. N. Engl. J. Med. 323 (1990) 1818-1822
48. Fleischhauer K., et al. Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain. Tissue Antigens 44 (1994) 311-317
49. Keever C.A., et al. HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation. Bone Marrow Transplant. 14 (1994) 137-145
50. Koelle D.M., et al. Herpes simplex virus type 2-specific CD8 cytotoxic T lymphocyte cross-reactivity against prevalent HLA class I alleles. Blood 99 (2002) 3844-3847
51. Burrows S.R., et al. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. J. Exp. Med. 179 (1994) 1155-1161
52. Steinle A., et al. Motif of HLA-B*3503 peptide ligands. Immunogenetics 43 (1996) 105-107
53. Keever C.A., et al. HLA-B44-directed cytotoxic T cells associated with acute graft-versus- host disease following unrelated bone marrow transplantation. Bone Marrow Transplant. 14 (1994) 137-145
54. Herman J., et al. Differences in the recognition by CTL of peptides presented by the HLA- B*4402 and the HLA-B*4403 molecules which differ by a single amino acid. Tissue Antigens 53 (1999) 111-121
55. Rossjohn J., and McCluskey J. How a home-grown T cell receptor interacts with a foreign landscape. Cell 129 (2007) 19-20
56. Lechler R.I., et al. The molecular basis of alloreactivity. Immunol. Today 11 (1990) 83-88
57. Lechler R.I., and Lombardi G. Structural aspects of allorecognition. Curr. Opin. Immunol. 3 (1991) 715-721
58. Lechler R.I., et al. Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses. Immunol. Lett. 34 (1992) 63-69
59. Lombardi G., et al. Allorecognition of DR1 by T Cells from a DR4/DRw13 responder mimics self-restricted recognition of endogenous peptides. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 4190-4194
60. Claas F.H., et al. Differential immunogenicity of HLA class I alloantigens for the humoral versus the cellular immune response: 'towards tailor-made HLA mismatching'. Hum. Immunol. 67 (2006) 424-429
61. Heemskerk M.B., et al. Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation. Bone Marrow Transplant. 40 (2007) 193-200
62. Borg N.A., et al. The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition. Nat. Immunol. 6 (2005) 171-180
63. Kjer-Nielsen L., et al. A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity. Immunity 18 (2003) 53-64
64. Sykulev Y., et al. High-affinity reactions between antigen-specific T cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 11487-11491
65. Speir J.A., et al. Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes. Immunity 8 (1998) 553-562
66. Tallquist M.D., et al. A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity. J. Exp. Med. 184 (1996) 1017-1026
67. Macdonald W., et al. Identification of a dominant self-ligand bound to three HLA B44 alleles and the preliminary crystallographic analysis of recombinant forms of each complex. FEBS Lett. 527 (2002) 27-32
68. Guimezanes A., et al. Identification of endogenous peptides recognized by in vivo or in vitro generated alloreactive cytotoxic T lymphocytes: distinct characteristics correlated with CD8 dependence. Eur. J. Immunol. 31 (2001) 421-432
69. Reiser J.B., et al. CDR3 loop flexibility contributes to the degeneracy of TCR recognition. Nat. Immunol. 4 (2003) 241-247
70. Guimezanes A., et al. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product. Eur. J. Immunol. 22 (1992) 1651-1654
71. Kern P., et al. Structural basis of CD8 coreceptor function revealed by crystallographic analysis of a murine CD8alphaalpha ectodomain fragment in complex with H-2Kb. Immunity 9 (1998) 519-530
72. Housset D., et al. The three-dimensional structure of a T cell antigen receptor V alpha V beta heterodimer reveals a novel arrangement of the V beta domain. EMBO J. 16 (1997) 4205-4216